- Home
- APLS vs PRGO Comparison
APLS vs PRGO Comparison
Compare APLS & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- PRGO
- Stock Information
- Founded
- APLS 2009
- PRGO 1887
- Country
- APLS United States
- PRGO Ireland
- Employees
- APLS N/A
- PRGO N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- APLS Health Care
- PRGO Health Care
- Exchange
- APLS Nasdaq
- PRGO Nasdaq
- Market Cap
- APLS 3.5B
- PRGO 3.1B
- IPO Year
- APLS 2017
- PRGO 1991
- Fundamental
- Price
- APLS $25.17
- PRGO $22.35
- Analyst Decision
- APLS Buy
- PRGO Buy
- Analyst Count
- APLS 20
- PRGO 4
- Target Price
- APLS $34.11
- PRGO $33.00
- AVG Volume (30 Days)
- APLS 2.1M
- PRGO 1.5M
- Earning Date
- APLS 11-04-2025
- PRGO 11-05-2025
- Dividend Yield
- APLS N/A
- PRGO 5.14%
- EPS Growth
- APLS N/A
- PRGO N/A
- EPS
- APLS N/A
- PRGO N/A
- Revenue
- APLS $754,649,000.00
- PRGO $4,326,100,000.00
- Revenue This Year
- APLS $20.59
- PRGO $2.28
- Revenue Next Year
- APLS N/A
- PRGO $0.54
- P/E Ratio
- APLS N/A
- PRGO N/A
- Revenue Growth
- APLS 20.02
- PRGO N/A
- 52 Week Low
- APLS $16.10
- PRGO $21.03
- 52 Week High
- APLS $39.51
- PRGO $30.93
- Technical
- Relative Strength Index (RSI)
- APLS 44.82
- PRGO 35.82
- Support Level
- APLS $27.26
- PRGO $22.00
- Resistance Level
- APLS $28.97
- PRGO $23.68
- Average True Range (ATR)
- APLS 0.99
- PRGO 0.53
- MACD
- APLS -0.58
- PRGO -0.01
- Stochastic Oscillator
- APLS 11.00
- PRGO 14.06
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.